By Forbes India| Mar 17, 2021
People sit under observation after receiving a dose of COVISHIELD, the coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, at an auditorium, which has been converted into a temporary vaccination centre in Ahmedabad, India, March 16, 2021.
Image: Amit Dave/ REUTERS